Literature DB >> 12639680

Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity.

Yao-Chi Chuang1, Michael B Chancellor, Satoshi Seki, Naoki Yoshimura, Pradeep Tyagi, Leaf Huang, John P Lavelle, William C De Groat, Matthew O Fraser.   

Abstract

OBJECTIVES: An acute animal model for hyperactive bladder in rats was developed using intravesical infusion of protamine sulfate (PS), an agent thought to break down urothelial barrier function, and physiologic concentrations of potassium chloride (KCl).
METHODS: Continuous cystometrograms (CMGs) were performed in urethane-anesthetized female rats by filling the bladder (0.04 mL/min) with normal saline followed by intravesical infusion of a test solution consisting of either KCl (100 or 500 mM) or PS (10 or 30 mg/mL) for 60 minutes. Subsequently, the 10 mg/mL PS-treated animals were infused intravesically with 100, 300, or 500 mM KCl. Some animals were pretreated with capsaicin (125 mg/kg subcutaneously) 4 days before the experiments.
RESULTS: Unlike KCl (100 or 500 mM) or a low concentration of PS (10 mg/mL) alone, the intravesical administration of a high concentration of PS (30 mg/mL) produced irritative effects with a decreased intercontraction interval (by 80.6%). After infusion of a low concentration of PS, infusion of 300 or 500 mM KCl produced irritative effects (intercontraction interval decreased by 76.9% or 82.9%, respectively). The onset of irritation occurred more rapidly after 500 mM KCl (10 to 15 minutes) than after 300 mM KCl (20 to 30 minutes). Capsaicin pretreatment delayed the onset (approximately 60 minutes) and reduced the magnitude (intercontraction interval decreased by 35.5%) of irritative effects.
CONCLUSIONS: Intravesical administration of KCl after PS treatment activates capsaicin-sensitive afferents and detrusor muscle and presumably capsaicin-resistant afferents. Modest, noncytotoxic affronts to urothelial barrier function can result in dramatic irritative responses. This model may be useful in the study of bladder irritation and hyperactivity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639680     DOI: 10.1016/s0090-4295(02)02280-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  15 in total

Review 1.  Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.

Authors:  Aram Kim; Dong-Myung Shin; Myung-Soo Choo
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

2.  Normalization of proliferation and tight junction formation in bladder epithelial cells from patients with interstitial cystitis/painful bladder syndrome by d-proline and d-pipecolic acid derivatives of antiproliferative factor.

Authors:  Susan Keay; Piotr Kaczmarek; Chen-Ou Zhang; Kristopher Koch; Zoltan Szekely; Joseph J Barchi; Christopher Michejda
Journal:  Chem Biol Drug Des       Date:  2011-04-27       Impact factor: 2.817

3.  Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model.

Authors:  Patrick O Wagers; Kristin M Tiemann; Kerri L Shelton; William G Kofron; Matthew J Panzner; Karen L Wooley; Wiley J Youngs; David A Hunstad
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

4.  Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observations.

Authors:  Charles W Butrick; Dan Sanford; Qingijiang Hou; Jonathan D Mahnken
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05-21

Review 5.  Acid-sensitive ion channels and receptors.

Authors:  Peter Holzer
Journal:  Handb Exp Pharmacol       Date:  2009

6.  Role of p75NTR in female rat urinary bladder with cyclophosphamide-induced cystitis.

Authors:  Mary Beth Klinger; Margaret A Vizzard
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-08

7.  Expression and function of CXCL12/CXCR4 in rat urinary bladder with cyclophosphamide-induced cystitis.

Authors:  Lauren Arms; Beatrice M Girard; Margaret A Vizzard
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-23

8.  Effects of intravesical prostaglandin E2 on bladder function are preserved in capsaicin-desensitized rats.

Authors:  James A Hokanson; Christopher L Langdale; Philip H Milliken; Arun Sridhar; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2020-12-07

9.  A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study.

Authors:  Susan Keay; Samantha Leitzell; Ashley Ochrzcin; George Clements; Min Zhan; David Johnson
Journal:  BMC Urol       Date:  2012-06-08       Impact factor: 2.264

10.  Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain.

Authors:  Maia Terashvili; Bhavana Talluri; Watchareepohn Palangmonthip; Kenneth A Iczkowski; Patrick Sanvanson; Bidyut K Medda; Banani Banerjee; Christopher W Cunningham; Jyoti N Sengupta
Journal:  Neuropharmacology       Date:  2021-07-10       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.